N/A
N=104
Does MiECC Improve Outcome in Diabetic Patients Undergoing Elective Coronary Bypass Grafting?
Acute Kidney Injury
Bottom Line
View on ClinicalTrials.gov: NCT02672514 ↗Enrolled (actual)
104
Serious AEs
18.3%
Results posted
Mar 2017
Primary outcome: Primary: Acute Kidney Injury — 7; 41; 9; 40 participants — p=0.377
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Minimally invasive extracorporeal circulation (MiECC) (Device); Conventional extracorporeal circulation (CECC) (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Herzzentrum Coswig
- Primary completion
- Apr 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acute Kidney Injury |
7; 41; 9; 40 | 0.377 |
Summary
The aim of this study was to prospectively evaluate MECC compared with conventional extracorporeal circulation of diabetic patients undergoing elective coronary revascularization procedures. The investigators focused on the effects of extracorporeal circulation especially the renal function between both groups.
Eligibility Criteria
Inclusion Criteria
- diabetes mellitus type 2
- isolated elective coronary revascularization
Exclusion Criteria
- urgent or emergent Status
- Re-Operation
- preexisting reanimation
- preexisting renal transplantation
- chronic kidney insufficiency (GFR < 30 ml/min)
- renal cell carcinoma
- renal artery Stenosis
- heart valve disease (middle- and high-grade)
- endocarditis
- infections (HIV, Tbc and all types of Hepatitis)
- hepatic cirrhosis
Data sourced from ClinicalTrials.gov (NCT02672514). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.